SeaStar Medical Holding Corporation (ICU)

0.4262 -0.0047 (-1.09%) As of 09:43AM EDT. Market open.

SeaStar Medical Holding Corporation

3513 Brighton Boulevard
Suite 410
Denver, CO 80216
United States
844 427 8100
https://www.seastarmedical.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Eric Schlorff	CEO, President & Executive Director	420k	N/A	1973
Colonel Kevin Chung FACP, M.D.	Chief Medical Officer	350k	N/A	1973
Dr. H. David Humes M.D.	Co-Founder and Managing Director	135.71k	N/A	N/A
Mr. David A. Green CPA, M.B.A.	Chief Financial Officer	N/A	N/A	1963
Tom Mullen	Vice President of Operations & Product Development	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Corporate governance

SeaStar Medical Holding Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.